AQR Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.38M | Sell |
|
|||||
|
2025
Q1 | $7.16M | Sell |
|
|||||
|
2024
Q4 | $7.39M | Buy |
|
|||||
|
2024
Q3 | $2.72M | Buy |
|
|||||
|
2024
Q2 | $609K | Buy |
|
|||||
|
2024
Q1 | $367K | Buy |
|
|||||
|
2023
Q4 | $154K | Sell |
|
|||||
|
2023
Q3 | $431K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $223K | Sell |
|
|||||
|
2022
Q4 | $385K | Sell |
|
|||||
|
2022
Q3 | $763K | Buy |
|
|||||
|
2022
Q2 | $598K | Sell |
|
|||||
|
2022
Q1 | $1.63M | Sell |
|
|||||
|
2021
Q4 | $2.33M | Buy |
|
|||||
|
2021
Q3 | $1.57M | Sell |
|
|||||
|
2021
Q2 | $1.18M | Buy |
|
|||||
|
2021
Q1 | $1.14M | Buy |
|
|||||
|
2020
Q4 | $814K | Buy |
|
|||||
|
2020
Q3 | $495K | Sell |
|
|||||
|
2020
Q2 | $611K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $455K | Sell |
|
|||||
|
2019
Q1 | $750K | Sell |
|
|||||
|
2018
Q4 | $827K | Buy |
|
|||||
|
2018
Q3 | $837K | Buy |
|
|||||
|
2018
Q2 | $365K | Sell |
|
|||||
|
2018
Q1 | $305K | Sell |
|
|||||
|
2017
Q4 | $860K | Buy |
|
|||||
|
2017
Q3 | $981K | Sell |
|
|||||
|
2017
Q2 | $922K | Sell |
|
|||||
|
2017
Q1 | $1.84M | Sell |
|
|||||
|
2016
Q4 | $2.04M | Sell |
|
|||||
|
2016
Q3 | $2.7M | Buy |
|
|||||
|
2016
Q2 | $1.55M | Buy |
|
|||||
|
2016
Q1 | $1.14M | Sell |
|
|||||
|
2015
Q4 | $2M | Sell |
|
|||||
|
2015
Q3 | $2.4M | Sell |
|
|||||
|
2015
Q2 | $4.76M | Buy |
|
|||||
|
2015
Q1 | $1.2M | Buy |
|
|||||
|
2014
Q4 | $497K | Buy |
|
|||||
|
2014
Q3 | $347K | Buy |
|